Armodafinil 150 mg/day
C10953/3025/AP/MN
Phase 3 small_molecule completed
Quick answer
Armodafinil 150 mg/day for Obstructive Sleep Apnea is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Obstructive Sleep Apnea
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed